$IPIX

OTC News Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Announces NIH/NIAID-Affiliated Researchers to Evaluate Brilacidin’s Treatment Potential Against Monkeypox 3 days, 8 hours ago

$IPIX

OTC News Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Provider and Payer Analysis Supports Potential Commercialization of Innovation Pharmaceutical’s Brilacidin as a Novel Oral Mucositis Drug Candidate 2 weeks, 3 days ago

OTC News Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Announces New Antiviral Research on Brilacidin in Bunyaviruses and Alphaviruses to be Presented at the 2022 Military Health System Research Symposium 1 month, 1 week ago

OTC News Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Reports Brilacidin Inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 Variants Based on In Vitro Testing by NIH/NIAID-Sponsored and Rutgers University Researchers 1 month, 2 weeks ago

OTC News Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Acquires Stake in Squalus Medical, Seeks to Reshape Cancer and Epilepsy Treatments Through a New Image Guided Laser-Based Ablation Technology 1 month, 3 weeks ago

OTC News Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Announces Publication of Peer-Review Article in the Journal of Medical Virology on Anti-Coronavirus Properties of Brilacidin 4 months, 3 weeks ago

OTC News Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Reports Additional Findings Based on Review of Brilacidin Phase 2 COVID-19 Trial Results and Compassionate Use Cases 5 months ago